Point72 Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Point72 Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,200	Closed	-$20K	–	1635
2019 Q2	$20K	Buy	+4,200	New	+$19.6K	﹤0.01%	1254
2019 Q1	–	Sell	-1,500,000	Closed	-$5.55M	–	1354
2018 Q4	$5.55M	Hold	1,500,000	–	–	0.03%	532
2018 Q3	$4.2M	Buy	1,500,000 +900,000	+150%	+$2.53M	0.02%	641
2018 Q2	$1.77M	Buy	+600,000	New	+$1.42M	0.01%	766
2015 Q4	–	Sell	-10,300	Closed	-$57K	–	977
2015 Q3	$57K	Sell	10,300 -6,600	-39%	-$48.7K	﹤0.01%	718
2015 Q2	$135K	Buy	16,900 +9,700	+135%	+$83.3K	﹤0.01%	679
2015 Q1	$76K	Buy	+7,200	New	+$98.4K	﹤0.01%	664

Other funds holding BDSI

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Point72 Asset Management's BDSI Position: Q3 2019 in Review

Point72 Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2019, closing a stake of 4,200 shares — an estimated $20K sold.

Point72 Asset Management first reported a position in BDSI in Q1 2015 and held it in 7 quarters. The position peaked at $5.55M in Q4 2018. 119 funds tracked by Wall St. Rank hold BDSI as of Q3 2019.

Point72 Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2019 after selling out during the quarter.
Point72 Asset Management sold 4,200 BioDelivery Sciences International, Inc. shares in Q3 2019, an estimated $20K.
Point72 Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 7 quarters.
Point72 Asset Management's BioDelivery Sciences International, Inc. position peaked at $5.55M in Q4 2018.
119 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2019.

Based on Point72 Asset Management's 13F filing for Q3 2019, filed 15 Nov 2019.